AF
AGIO icon

Advisornet Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Advisornet Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,532
Closed -$34.1K – 2043
2023
Q4 		$34.1K Hold
1,532
– – ﹤0.01% 926
2023
Q3 		$37.9K Hold
1,532
– – ﹤0.01% 866
2023
Q2 		$43.4K Buy
1,532
+2
+0.1% +$50 ﹤0.01% 854
2023
Q1 		$35.1K Sell
1,530
-2
-0.1% -$53 ﹤0.01% 894
2022
Q4 		$43K Buy
1,532
+2
+0.1% +$56 ﹤0.01% 830
2022
Q3 		$43K Hold
1,530
– – ﹤0.01% 886
2022
Q2 		$34K Hold
1,530
– – ﹤0.01% 983
2022
Q1 		$45K Hold
1,530
– – ﹤0.01% 996
2021
Q4 		$50K Hold
1,530
– – ﹤0.01% 1011
2021
Q3 		$71K Hold
1,530
– – ﹤0.01% 899
2021
Q2 		$84K Hold
1,530
– – 0.01% 827
2021
Q1 		$79K Hold
1,530
– – 0.01% 816
2020
Q4 		$66K Buy
1,530
+650
+74% +$25.7K 0.01% 799
2020
Q3 		$31K Hold
880
– – ﹤0.01% 969
2020
Q2 		$47K Hold
880
– – ﹤0.01% 875
2020
Q1 		$31K Buy
+880
New +$40.7K ﹤0.01% 943

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advisornet Financial's AGIO Position: Q1 2024 in Review

Advisornet Financial sold out of Agios Pharmaceuticals (AGIO) in Q1 2024, closing a stake of 1,532 shares — an estimated $34.1K sold.

Advisornet Financial first reported a position in AGIO in Q1 2020 and held it in 16 quarters. The position peaked at $84K in Q2 2021. 186 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Advisornet Financial reported no remaining Agios Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 1,532 Agios Pharmaceuticals shares in Q1 2024, an estimated $34.1K.
  • Advisornet Financial first reported a position in Agios Pharmaceuticals in Q1 2020 and held it in 16 quarters.
  • Advisornet Financial's Agios Pharmaceuticals position peaked at $84K in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.